Nova Patents
AT544748T

Compositions and methods of treating cell proliferation disorders

Abstract

The present invention relates to compounds and methods for treating cell proliferative disorders.

Term

Term ended

Expired 28 December 2025, 0.7 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

79 members in 21 offices

This recordMember, by publication datePriority claim11 more offices are in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
63983404United States of AmericaP
70455105United States of AmericaP
72734105United States of AmericaP
2005047333United States of AmericaW

Members79

Family members, oldest first
DocumentOfficeKind
AU2005321966A1AustraliaA1
CA2594345A1CanadaA1
WO2006071960A2World Intellectual Property Organization (WIPO)A2
US2006160800A1United States of AmericaA1
US2007015752A1United States of AmericaA1
WO2006071960A3World Intellectual Property Organization (WIPO)A3
US2007197783A1United States of AmericaA1
EP1836169A2European Patent Office (EPO)A2
KR20070099622ARepublic of KoreaA
US7300931B2United States of AmericaB2
TW200800952ATaiwan Province of ChinaA
AU2007265373A1AustraliaA1
CA2656564A1CanadaA1
WO2008002676A2World Intellectual Property Organization (WIPO)A2
WO2008002676A3World Intellectual Property Organization (WIPO)A3
HK1108695A1Hong Kong, ChinaA1
CN101184734AChinaA
WO2008002676A9World Intellectual Property Organization (WIPO)A9
JP2008525530AJapanA
WO2008127728A1World Intellectual Property Organization (WIPO)A1
BRPI0519424A2BrazilA2
EP2041071A2European Patent Office (EPO)A2
IL196168D0IsraelD0
CN101595084AChinaA
JP2009542680AJapanA
US2010249130A1United States of AmericaA1
US2011065705A1United States of AmericaA1
US7968574B2United States of AmericaB2
US8003641B2United States of AmericaB2
US2011237586A1United States of AmericaA1
AU2005321966B2AustraliaB2
EP1836169B1European Patent Office (EPO)B1
AT544748TThis recordAustriaT
DK1836169T3DenmarkT3
JP2012082222AJapanA
ES2382068T3SpainT3
EP1836169B9European Patent Office (EPO)B9
PL1836169T3PolandT3
US8236799B2United States of AmericaB2
US2012270874A1United States of AmericaA1
CN101595084BChinaB
JP5124285B2JapanB2
AU2007265373B2AustraliaB2
CN101184734BChinaB
TWI398440BTaiwan Province of ChinaB
KR20130079661ARepublic of KoreaA
CN103274961AChinaA
CA2594345CCanadaC
KR101328273B1Republic of KoreaB1
US8598169B2United States of AmericaB2
HK1188985A1Hong Kong, ChinaA1
EP2041071B1European Patent Office (EPO)B1
JP5564251B2JapanB2
US2014213587A1United States of AmericaA1
DK2041071T3DenmarkT3
PT2041071EPortugalE
ES2500165T3SpainT3
SI2041071T1SloveniaT1
KR101478933B1Republic of KoreaB1
US8980890B2United States of AmericaB2
CA2656564CCanadaC
US2015182532A1United States of AmericaA1
IL196168AIsraelA
CN103274961BChinaB
CY1114825T1CyprusT1
CY1115691T1CyprusT1
US9580387B2United States of AmericaB2
US9655903B2United States of AmericaB2
US2017196874A1United States of AmericaA1
IL242374AIsraelA
US10196357B2United States of AmericaB2
US2019367456A1United States of AmericaA1
BRPI0519424B1BrazilB1
BRPI0519424B8BrazilB8
US2021252008A1United States of AmericaA1
NL301145I1Netherlands (Kingdom of the)I1
NL301145I2Netherlands (Kingdom of the)I2
HUS2100051I1HungaryI1
US2022119347A1United States of AmericaA1